Rozel 60Mg Injection

Name: Rozel 60Mg Injection
Brand: ONCOTRUST
Price: 5998.0 INR
Availability: InStock

Price 5998.0 INR/ Parcel

Get a Price/Quote

MOQ : 1 Piece

Rozel 60Mg Injection Specification

Dosage Form
Injection

Indication
Treatment of osteoporosis, bone loss, and certain bone cancers

Salt Composition
Denosumab 60mg

Feature
Ready-to-use, single-use prefilled syringe

Ingredients
Denosumab

Application
Administered by subcutaneous injection for bone-related conditions

Ph Level
Neutral pH (approximately 6.0) in formulation

Temperature Needed For Fermentation
rankine Rankine

Physical Color/Texture
Other

Fermentation Smell
Normal Smell

Storage Instructions
Store in a refrigerator (2C to 8C). Do not freeze. Protect from light.

Shelf Life
24 months from manufacture

Brand Name
Rozel 60 mg

Container Type
Prefilled syringe

Frequency of Administration
Once every 6 months

Common Side Effects
Musculoskeletal pain, hypercholesterolemia, injection site reaction, hypocalcemia

Molecular Weight
147 kDa (Denosumab)

ATC Code
M05BX04

Prescription Status
Prescription only

Route of Administration
Subcutaneous

Packing Size
Prefilled syringe of 1 ml

Contraindications
Hypocalcemia, hypersensitivity to product

Rozel 60Mg Injection Trade Information

Minimum Order Quantity
1 Piece

Delivery Time
24 Hours

About Rozel 60Mg Injection

Rozel 60mg Injection is a high-quality anticancer medication widely used in the treatment of various solid tumors. It contains Denosumab 60 mg, a monoclonal antibody that works by inhibiting bone resorption and reducing skeletal-related events in patients with cancer involving the bones. It is administered under the supervision of a qualified healthcare professional.
Key Benefits
- Helps prevent bone complications in cancer patients
- Reduces risk of fractures and bone pain
- Improves bone strength by inhibiting osteoclast activity
- Proven efficacy in oncology-related bone disorders
Composition
- Active Ingredient: Denosumab 60 mg
- Dosage Form: Injection
Therapeutic Uses
- Bone metastasis associated with solid tumors
- Prevention of skeletal-related events in cancer patients
- Management of cancer-induced bone loss
Administration
- For subcutaneous injection only
- To be administered by a medical professional as prescribed
Storage Instructions
- Store at 2C to 8C (Refrigerated)
- Do not freeze
- Protect from light
Precautions
- Prescription drug; use only under medical supervision
- Not recommended during pregnancy unless advised by a physician
- Regular monitoring of calcium levels is recommended
Packaging
- Single-use vial / prefilled syringe (as available)

How Rozel 60mg Injection Works

Rozel 60mg Injection operates by inhibiting a protein, RANKL, involved in bone breakdown. By blocking this protein, the medication helps slow bone loss, increase bone density, and reduce the risk of fractures. The effect is particularly beneficial for individuals suffering from osteoporosis, bone loss due to cancer therapies, or certain bone metastases. The once-every-six-months dosing offers an extended protective effect against bone weakening.

Administration and Usage Recommendations

Rozel 60mg is administered as a single subcutaneous injection, usually by a healthcare professional. The formulation comes in a prefilled, sterile syringe that is single-use only. Patients should not self-administer unless specifically trained. It is crucial to ensure calcium and vitamin D levels are adequate prior to receiving the injection to minimize the risk of hypocalcemia.

Storage and Handling Instructions

Rozel 60mg Injection must be stored in a refrigerator at 2C to 8C. It should not be frozen and must be kept protected from light. If it is inadvertently frozen, the syringe should not be used. Proper storage assures the stability and effectiveness of the medication throughout its 24-month shelf life.

FAQ's of Rozel 60Mg Injection:

Q: How should Rozel 60mg Injection be stored and handled?

A: Rozel 60mg Injection should be stored in a refrigerator between 2C and 8C. Do not freeze the injection, and keep it protected from light. Upon removal from the refrigerator, it should be brought to room temperature before use, and any unused syringe must be discarded.

Q: What is the recommended process for administering Rozel 60mg Injection?

A: Rozel 60mg should be administered as a single subcutaneous injection once every six months, ideally by a healthcare professional. The prefilled syringe is ready-to-use and intended for single use only. Patients should not attempt self-injection unless appropriately trained.

Q: When is Rozel 60mg Injection typically prescribed?

A: Rozel 60mg Injection is prescribed for the treatment of osteoporosis in adults at increased risk for fractures, bone loss due to certain cancer treatments, and in some cases of bone metastases from solid tumors. It must be prescribed by a qualified healthcare provider.

Q: What precautions should be taken before using Rozel 60mg Injection?

A: Before receiving Rozel 60mg, ensure your calcium and vitamin D levels are within the recommended range to reduce the risk of hypocalcemia. It must not be used if you have hypocalcemia or known hypersensitivity to Denosumab or any ingredient in the product.

Q: What are the possible side effects associated with Rozel 60mg Injection?

A: The most common side effects include musculoskeletal pain, hypercholesterolemia, injection site reactions, and hypocalcemia. Patients should contact their healthcare provider if they experience symptoms of low calcium levels, such as muscle cramps or tingling.

Q: How does Rozel 60mg Injection benefit patients with osteoporosis?

A: Rozel 60mg Injection strengthens bones by reducing bone resorption, leading to increased bone density and a decreased risk of fractures. The convenience of a once every six months schedule improves patient adherence and overall treatment outcomes.

Tell us about your requirement